Curated scientific studies with plain-English summaries and multi-paradigm interpretation
Showing 5 studies
Keum N, et al • Annals of Oncology • 2019
Cancer mortality: 13% reduction (RR 0.87, 95% CI 0.79-0.96, p=0.005); Cancer incidence: no effect (RR 0.98, 95% CI 0.93-1.03, p=0.42)
Ridker PM • J Am Coll Cardiol • 2007
hsCRP independently predicts myocardial infarction, stroke, diabetes, and all-cause mortality
Gami AS, et al. • Journal of the American College of Cardiology • 2007
Metabolic syndrome was associated with approximately 2-fold increased risk of cardiovascular events (RR ~2.0) and 1.5-fold increased risk of all-cause mortality across studies.
Ruttmann E, Brant LJ, Concin H, et al. • Circulation • 2005
Upper-normal GGT increases cardiovascular mortality by 64% in men
Cui Y, et al. • Archives of Internal Medicine • 2001
A 30 mg/dL increase in non-HDL-C corresponded to 19% increased CVD risk in men (vs 15% for LDL-C) and 11% in women (vs 8% for LDL-C).